Legarreta v. Macias

CourtDistrict Court, D. New Mexico
DecidedMay 6, 2022
Docket2:21-cv-00179
StatusUnknown

This text of Legarreta v. Macias (Legarreta v. Macias) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Legarreta v. Macias, (D.N.M. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO

ISAAC LEGARETTA, and JOHN or JANE DOES 1-20,

Plaintiff, Case No. 21-cv-179 MV/GBW vs.

FERNANDO MACIAS, Dona Ana County Manager, DIRECTOR BRYAN BAKER, an Official with the Dona Ana County Detention Center, CAPTAIN BEN MENDOZA, an official with the Dona Ana County Detention Center, CAPTAIN JOSHUA FLEMING, an official with the Dona Ana County Detention Center, COUNTY OF DONA ANA and JOHN or JANE DOES 1-20,

Defendants.

MEMORANDUM OPINION AND ORDER

THIS MATTER comes before the Court on Defendants Macias, Baker, Mendoza, Fleming and County of Dona Ana’s Motion to Dismiss in Lieu of an Answer (“Motion to Dismiss”) [Doc. 20] and Plaintiffs’ Motion to Strike [Doc. 26]. The Court, having considered the motions and the relevant law, finds that Defendants’ Motion to Dismiss is well-taken and will be granted and Plaintiffs’ Motion to Strike is not well-taken and will be denied. BACKGROUND Since its emergence last year, the novel coronavirus 2019, or Sars-CoV-2, the virus that causes COVID-19, has spread exponentially through the world, and New Mexico has been no exception. Governor Michelle Lujan Grisham first declared the existence of a Public Health Emergency in New Mexico in March 2020, when COVID-19 reached our State, and has since 1 renewed that declaration. See Executive Order 2022-024 (Apr. 29, 2022), https://cv.nmhealth.org/public-health-orders-and-executive-orders/ (hereinafter referred to as “NM Health Website”). As of April 15, 2022, over 79 million people have been infected with COVID-19 in the United States, with over 1,000,000 related deaths, and the New Mexico Department of Health (“DOH”) has reported over 519,000 positive COVID-19 cases and 7,400

related deaths in New Mexico. See April 15, 2022 Public Health Order, NM Health Website. Efforts to develop and distribute a vaccine against COVID-19 were swift. In December 2020, the FDA granted emergency use authorizations (“EUA”) for the Pfizer/BioNTech (“Pfizer”) two-dose mRNA vaccine for individuals 16 and older and for the Moderna two-dose mRNA vaccine for individuals 18 and older. See FDA News Release (Dec. 11, 2020), https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against- covid-19-issuing-emergency-use-authorization-first-covid-19; FDA News Release (Dec. 18, 2020), https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight- against-covid-19-issuing-emergency-use-authorization-second-covid. In February 2021, the

FDA granted EUA for the Johnson & Johnson vaccine for individuals 18 and older. FDA News Release (Feb. 27, 2021), https://www.fda.gov/news-events/press-announcements/fda-issues- emergency-use-authorization-third-covid-19-vaccine. In May 2021, Pfizer’s vaccine received EUA for individuals 12 and older, and then in August 2021, full FDA approval for individuals 16 and older. See FDA News Release (May 10, 2021), https://www.fda.gov/news-events/press- announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine- emergency-use; FDA News Release (August 23, 3021), https://www.fda.gov/news-events/press- announcements/fda-approves-first-covid-19-vaccine. In October 2021, the FDA authorized the emergency use of Pfizer’s vaccine for children five through 11 years of age. See FDA News

2 Release (Oct. 29, 2021), https://www.fda.gov/news-events/press-announcements/fda-authorizes- pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age. In November 2021, the FDA amended the EUA for both the Moderna and Pfizer vaccines, authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine.

See FDA News Release (Nov. 19, 2021), https://www.fda.gov/news-events/press- announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters. In December 2021 and January 2022, the FDA again amended the EUA for the Pfizer vaccine, expanding authorization of booster doses to individuals 12 to 17 years of age, at least five months after completion of primary vaccination with the Pfizer vaccine. See FDA News Release (Dec. 9, 2021), https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19- update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17; FDA News Release (Jan. 3, 2022), https://www.fda.gov/news-events/press-announcements/coronavirus- covid-19-update-fda-takes-multiple-actions-expand-use-pfizer-biontech-covid-19-vaccine. And

on March 29, 2022, the FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. FDA News Release (Mar. 29, 2022), https://www.fda.gov/news-events/press- announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19- vaccines-older-and. The DOH has advised that: “the currently available COVID-19 vaccines are safe and the most effective way of preventing infection, serious illness, and death”; “widespread vaccination protects New Mexico’s health care system as vaccines decrease the need for emergency services and hospitalization”; and “the refusal to receive the COVID-19 vaccine not only endangers the individual but the entire community, and further jeopardizes the

3 progress the State has made against the pandemic by allowing the virus to transmit more freely and mutate into more transmissible or deadly variants.” August 17, 2021 Public Health Order (“August 17, 2021 PHO”), NM Health Website. Against this backdrop, on January 29, 2021, Dona Ana County Manager Fernando Macias issued a memorandum to “All Dona County First Responders,” regarding “Mandatory

Covid-19 Vaccine Directive” (“Vaccine Directive”). Doc. 17 at 25. Macias’s memo explained: “in accordance with the County’s duty to provide and maintain a workplace that is free of known hazards, we are adopting a mandatory COVID-19 vaccination directive to safeguard the health of our employees, their families, the customers we serve, and the community at large from this highly contagious, infectious disease.” Id. The memo further indicated that the Vaccine Directive “takes into account all applicable laws and guidance from local health authorities.” Id. Under the Vaccine Directive, “all first responders,” including “detention officers and other staff who have face-to-face contact with inmates,” are “required to receive the COVID-19 vaccination unless a reasonable accommodation is approved.” Id. The memo required that first responders

receive the first dose of the vaccine by February 5, 2021, and made clear that “[b]eing vaccinated [was] a requirement and a condition of on-going employment with the County due to the significant health and safety risks posed by contracting or spreading COVID-19.” Id. at 26. At the time that Macias issued the Vaccine Directive, Plaintiffs Isaac Legaretta and Anthony Zoccoli were employed at the Dona Ana County Detention Center (the “Detention Center”). Doc. 17 ¶ 4. On February 17, 2021, Legaretta signed a “Coaching/Counseling Acknowledgement” (“Acknowledgment”), which referenced the Vaccine Directive and noted that the Director of the Detention Center, Bryan Baker, had sent a follow-up email to all Detention Center staff “with a requirement that all individuals with access to the secure area of

4 the facility are mandated to have received their first dose of their vaccination by February 5, 2021, unless there is a documented ADA or EEO exception granted by Human Resources.” Doc. 17 at 27. The Acknowledgement states that, as of February 17, 2021, Legaretta had “not provided proof of receiving the COVID-19 vaccination or having registered for the vaccination.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobson v. Massachusetts
197 U.S. 11 (Supreme Court, 1905)
Collins v. Texas
223 U.S. 288 (Supreme Court, 1912)
Zucht v. King
260 U.S. 174 (Supreme Court, 1922)
Kelley v. Johnson
425 U.S. 238 (Supreme Court, 1976)
City of Cleburne v. Cleburne Living Center, Inc.
473 U.S. 432 (Supreme Court, 1985)
Washington v. Glucksberg
521 U.S. 702 (Supreme Court, 1997)
Conn v. Gabbert
526 U.S. 286 (Supreme Court, 1999)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Brooks v. Gaenzle
614 F.3d 1213 (Tenth Circuit, 2010)
Powers v. Harris
379 F.3d 1208 (Tenth Circuit, 2004)
Seegmiller v. LaVerkin City
528 F.3d 762 (Tenth Circuit, 2008)
Smith v. United States
561 F.3d 1090 (Tenth Circuit, 2009)
Dias v. City and County of Denver
567 F.3d 1169 (Tenth Circuit, 2009)
Brown v. Montoya
662 F.3d 1152 (Tenth Circuit, 2011)
Guttman v. Khalsa
669 F.3d 1101 (Tenth Circuit, 2012)
Mobley v. Mccormick
40 F.3d 337 (Tenth Circuit, 1994)
Koontz v. St. Johns River Water Management Dist.
133 S. Ct. 2586 (Supreme Court, 2013)
Doe v. Rumsfeld
297 F. Supp. 2d 119 (District of Columbia, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Legarreta v. Macias, Counsel Stack Legal Research, https://law.counselstack.com/opinion/legarreta-v-macias-nmd-2022.